Product Information
DOXYLAMINE-PYRIDOXINE 10-10 MG is a generic product labeled by Analog Pharma, priced at $1.0916 per EA under NDC 70505010010. Its NADAC has been published 368 times since Sep 18, 2019.
FDA first approved this application on Apr 8, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 10 mg/1; mg/1
Manufacturer
Analog PharmaNDC
70505010010
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021876FDA Approved
4/8/2013
TE Code
AB
On Market Since
11/15/2018
Pharmacological Classes
Price Statistics
The NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has been published 368 times since Sep 18, 2019, and over the history we have for it it has declined 78.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0916 per EA |
|---|---|
| All-time high | $5.3468 (Sep 15, 2021) |
| All-time low | $0.9736 (Jul 17, 2024) |
| 52-week high | $1.3056 |
| 52-week low | $1.0916 |
| Median price | $2.0932 |
| Average price | $2.5737 |
| Largest weekly change | +68.5% (Jun 19, 2024) |
| Weeks tracked | 368 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Analog Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxylamine succinate and pyridoxine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYLAMINE-PYRIDOXINE 10-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for DOXYLAMINE-PYRIDOXINE 10-10 MG, manufactured by Analog Pharma, is $1.0916 per EA (NDC 70505010010), effective Sep 30, 2026.
How has the price of DOXYLAMINE-PYRIDOXINE 10-10 MG changed over time?
Over the history we have for it, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has declined 78.6%. It has been tracked across 368 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for DOXYLAMINE-PYRIDOXINE 10-10 MG?
Since Sep 18, 2019, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has ranged from a low of $0.9736 (Jul 17, 2024) to a high of $5.3468 (Sep 15, 2021), with a median of $2.0932 per EA.
Are there cheaper alternatives to DOXYLAMINE-PYRIDOXINE 10-10 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYLAMINE-PYRIDOXINE 10-10 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYLAMINE-PYRIDOXINE 10-10 MG?
DOXYLAMINE-PYRIDOXINE 10-10 MG (NDC 70505010010) is labeled by Analog Pharma, and CMS classifies it as a generic product.